Optimal allocation of sample sizes to multicenter clinical trials

J Biopharm Stat. 2013;23(4):818-28. doi: 10.1080/10543406.2013.789884.

Abstract

In this article, we discuss an approach for optimal sample size allocation in designing multicenter clinical trials. The method we studied was adapted from a stratified sampling survey design. The sample size allocated to centers is a function of the center's treatment cost, the standard deviation of the endpoint, and the availability of patients. We illustrate our approach using two hypothetical scenarios derived from our experiences in designing and conducting multicenter clinical trials. Simulation results are also presented.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials as Topic / economics
  • Clinical Trials as Topic / methods
  • Clinical Trials as Topic / statistics & numerical data*
  • Computer Simulation
  • Cost-Benefit Analysis
  • Humans
  • Models, Statistical*
  • Multicenter Studies as Topic / economics
  • Multicenter Studies as Topic / methods
  • Multicenter Studies as Topic / statistics & numerical data*
  • Research Design / statistics & numerical data
  • Sample Size